Skip to main content
Primary Health Care Research & Development logoLink to Primary Health Care Research & Development
. 2024 Feb 12;25:e12. doi: 10.1017/S1463423623000713

Primary care practice-based interventions and their effect on participation in population-based cancer screening programs: a systematic narrative review

Ebony J Verbunt 1,, Grace Newman 1, Nicola S Creagh 1, Kristi M Milley 2, Jon D Emery 2, Margaret A Kelaher 1,†,#, Nicole M Rankin 1, Claire E Nightingale 1
PMCID: PMC10894721  PMID: 38345096

Abstract

Aim:

To provide a systematic synthesis of primary care practice-based interventions and their effect on participation in population-based cancer screening programs.

Background:

Globally, population-based cancer screening programs (bowel, breast, and cervical) have sub-optimal participation rates. Primary healthcare workers (PHCWs) have an important role in facilitating a patient’s decision to screen; however, barriers exist to their engagement. It remains unclear how to best optimize the role of PHCWs to increase screening participation.

Methods:

A comprehensive search was conducted from January 2010 until November 2023 in the following databases: Medline (OVID), EMBASE, and CINAHL. Data extraction, quality assessment, and synthesis were conducted. Studies were separated by whether they assessed the effect of a single-component or multi-component intervention and study type.

Findings:

Forty-nine studies were identified, of which 36 originated from the USA. Fifteen studies were investigations of single-component interventions, and 34 studies were of multi-component interventions. Interventions with a positive effect on screening participation were predominantly multi-component, and most included combinations of audit and feedback, provider reminders, practice-facilitated assessment and improvement, and patient education across all screening programs. Regarding bowel screening, provision of screening kits at point-of-care was an effective strategy to increase participation. Taking a ‘whole-of-practice approach’ and identifying a ‘practice champion’ were found to be contextual factors of effective interventions.

The findings suggest that complex interventions comprised of practitioner-focused and patient-focused components are required to increase cancer screening participation in primary care settings. This study provides novel understanding as to what components and contextual factors should be included in primary care practice-based interventions.

Keywords: bowel cancer screening, breast cancer screening, cervical screening, practice-based interventions, primary care, primary healthcare workers

Introduction

The success of population-based cancer screening programs in reducing cancer mortality is often limited by sub-optimal participation in the community. Fifty percent of the eligible population participate in Germany’s Mammography Screening Program (Hand, 2020), while less than half (44%) participate in Australia’s National Bowel Cancer Screening Program (Australian Instititute of Health and Welfare, 2020). Scotland and Canada have participation rates between 60% and 81% for their breast and cervical screening programs. However, lower participation rates are observed in these countries' bowel screening programs (McCowan et al., 2019; Ontario Health, 2021). Many patient-level barriers have been described, including low awareness of program existence (Ferdous et al., 2018; Suwankhong and Liamputtong, 2018), worry about the procedure or outcome (Ferdous et al., 2018; Suwankhong and Liamputtong, 2018; Muthukrishnan et al., 2019), and time and transport required to attend screening (Suwankhong and Liamputtong, 2018; Muthukrishnan et al., 2019). People can be encouraged to engage with screening programs through invitations (Radde et al., 2016), small and mass media campaigns (Durkin et al., 2019; Schliemann et al., 2019), and through other prompts, such as celebrity cancer diagnosis, which have been shown to result in increased screening appointments and call to helplines (Boudioni et al., 1998; Chapman et al., 2005). Importantly, endorsement of screening by a primary healthcare worker (PHCW) is an important facilitator in a patient’s decision to screen (Duffy et al., 2017). However, PHCWs often experience challenges in engaging in screening programs, with barriers including the financial structure of primary care, the structure of screening programs, time, and screening knowledge (Wender, 1993; Yarnall et al., 2003; Verbunt et al., 2022).

The role of PHCWs, including family physicians/general practitioners (GPs) 1 and practice nurses, in cancer screening programs differs between countries and programs. Accredited PHCWs are responsible for facilitating screening tests in most cervical screening programs (Fontham et al., 2020; Australian Government Department of Health, 2021b). As mammography screening mostly occurs outside of primary care, PHCWs play a less direct but important role in promoting participation and facilitating follow-up care (Klarenbach et al., 2018; The Royal Australian College of General Practitioners, 2018). For bowel cancer screening, the role of PHCWs differs according to the program structure. In the US and Canada, family physicians are responsible for recommending, performing, or referring patients to different screening modalities, including colonoscopy and fecal occult blood test (FOBT) (Canadian Task Force on Preventive Health, 2001; Force et al., 2016). However, in countries such as the United Kingdom and Australia, eligible participants receive a fecal immunochemical test or FOBT screening kit via mail and have the option to nominate their GP to receive results and provide follow-up care (National Health Service, 2021; Australian Government Department of Health, 2021a).

Reviews, although not systematic, exist on the effect of interventions addressing practitioner-level barriers to engaging in cancer screening. A 2012 review concluded that the engagement of PHCWs and screening participation could be improved by using audit and feedback systems and office-system prompts, such as reminders for the clinician to discuss or order cancer screening tests (Emery et al., 2012). A more recent review found interactive and multi-faceted continuous medical education, training with audit and feedback, enablement through IT-based systems, and collaborative team-based interventions can modify PHCW’s practice and improve patient outcomes (Chauhan et al., 2017). However, this review was not specific to cancer screening, nor did it discuss any magnitude of effect on cancer screening participation. Further, contextual factors, defined as the ‘features of the circumstances in which an intervention is implemented that may interact with the intervention to produce variation in outcomes’, were not outlined (Craig et al., 2018). Contextual factors, such as workload and leadership, are an important consideration for understanding how, and under what circumstances interventions create change (Moore et al., 2015; Skivington et al., 2021).

Thus, it is unclear how to best optimize the role of PHCWs to increase cancer screening participation. This review aims to provide a systematic synthesis of primary care practice-based interventions and their effect on participation in population-based cancer screening programs. Contextual factors of effective interventions will be summarized. Findings from this review can be used to guide the development of interventions using PHCWs to facilitate greater participation in bowel, breast, and cervical screening programs.

Methods

The review is structured in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement (Page et al., 2021). The review protocol was registered with the International Prospective Register for Ongoing Systematic Reviews; CRD42020201118. All components of the protocol were adhered to; however, for clarity purposes, the outcome of interest was limited to screening uptake. Search terms were developed with the assistance of a research librarian (Appendix 1). Medline (OVID), EMBASE, and CINAHL were searched for articles published from 1st January 2010 to 23rd November 2023. Reference lists of included articles were searched for additional studies.

Study selection

Inclusion and exclusion criteria

Articles were included if they met the following criteria: (1) Randomized controlled trials (RCTs), non-randomized trials; (2) Intervention conducted in a high-income country (The World Bank, 2022); (3) Focused on the effect of a primary care practice-based intervention(s) to optimize the role of PHCWs in population-based cancer screening program (bowel, breast, and cervical); (4) Measures screening participation as an outcome; and (5) Published in English. Articles were excluded if they met any of the following criteria: (1) Reviews, protocols, and conference abstracts; (2) Impact of the intervention measured outside of a primary care setting; (3) Not focused on primary care practice-based intervention(s) to optimize the role of PHCWs in population-based cancer screening programs (bowel, breast, and cervical); (4) Intervention not targeted at a PHCW; and (5) Screening participation not included as an outcome.

Search results were imported into Covidence (Babineau, 2014) and duplicates were excluded. Two authors (EV, NC) independently screened titles and abstracts for relevance and three authors (EV, NC, CN) independently assessed the eligibility of full-text articles. The authors discussed disagreements to reach a consensus.

Data extraction and synthesis

A data extraction tool was developed for the review and piloted independently by two authors (EV, CN) who met several times to reach a consensus on the final information to be extracted. Three authors (EV, GN, CN) independently extracted: authors; year of publication; country; screening program; study type; population; sample size; intervention components; comparison; follow-up time; effect on screening participation; and contextual factors of intervention. Contextual factors that were explicitly outlined in studies surrounding primary care practice-based interventions were extracted.

Intervention components were categorized as practice-focused or patient-focused, with each category divided into sub-categories (Table 1). Because of the heterogeneity of interventions and study designs, we did not undertake meta-analysis, instead using narrative synthesis to summarize data (Popay et al., 2006). Studies were categorized by whether they assessed the effect of a single-component or multi-component intervention and study type.

Table 1.

Practice-focused and patient-focused intervention components

Practice-focused
Component of intervention Definition
Audit and feedback A systematic collection of data on cancer screening professional performance based on criteria or standards subsequently fed back to practitioners in a structured manner
Reminders Paper or electronic reminders to practitioners to discuss cancer screening with patients or to conduct cancer screening
Financial incentives A practitioner or practice payment received for engaging patients in a screening test or for participating in a cancer screening intervention
Education and/or training Improving a practitioner’s knowledge, such as understanding of cancer screening guidelines or skills, such as the ability to communicate effectively with patients
Behavior change techniques Implementing techniques, such as anticipated regret, which are designed to change a practitioner’s behavior
Practice-facilitated assessment and improvement Based on a review of current practice activities, multiple practice activities are undertaken to facilitate the delivery of cancer screening

Quality assessment

To assess the quality of randomized and non-randomized studies, the Downs and Black Checklist was used (Downs and Black, 1998). The checklist has 27 questions within five categories: reporting [10 items], external validity [3 items], internal validity/bias [7 items], internal validity/confounding [6 items], and power [1 item]. Item 27 (power) was modified. Studies were rated on whether or not they performed an a priori power calculation, with the maximum score for this item being 1 rather than 5. The highest possible score for the checklist was therefore 28 instead of 32. Two authors (EV, NC) independently assessed each article, meeting to discuss and resolve discrepancies. Articles were rated as being of excellent (26–28); good (20–25); fair (15–19); or poor (≤14) quality (Hooper et al., 2008).

Results

Study selection

We identified 1564 studies, with 133 duplicate studies removed before screening. Following title and abstract screening, we excluded 1335 studies, leaving 96 studies for full-text screening. Following full-text screening, we excluded 47 studies (Fig. 1), with 49 studies therefore included in our systematic synthesis. No additional studies were found when searching the reference lists of included studies.

Figure 1.

Figure 1.

Prisma diagram of study selection

Critical appraisal

Overall, RCTs had a mean score of 22 (good) and non-randomized trials 17 (fair). RCTs had a higher mean score than non-randomized trials in internal validity/confounding (4 versus 2), with similar mean scores in the remaining methodological categories – reporting (9 versus 8), external validity (3 versus 3), and internal validity/bias (4 versus 4) (Appendix 2).

Study characteristics

Characteristics of studies

Studies originated from the US (n = 36), Canada (n = 5), Australia (n = 3), France (n = 2), Norway (n = 1), Netherlands (n = 1), and Spain (n = 1). Study designs included RCTs (n = 19) and non-randomized trials (n = 28). Interventions focused on increasing participation in bowel screening (n = 27), six targeted cervical screening, two breast screening, and 14 studies focused on a combination of all three screening programs. Fifteen studies were investigations of single-component interventions, including seven RCTs, and eight non-randomized trials. Thirty-four studies included multi-component interventions, of which 12 were RCTs, and 22 were non-randomized trials (Fig. 2).

Figure 2.

Figure 2.

Characteristics of studies.

Single-component – RCTs

Seven studies from the US (n  = 3), France (n  = 2), Spain (n  = 1), and Canada (n  = 1) were single-component RCTs (Dignan et al., 2014; Aubin-Auger et al., 2016; Guiriguet and Castells, 2016; Rat et al., 2017; Wang et al., 2018; Hwang et al., 2019; Vaisson et al., 2019) (Table 2).

Table 2.

Overview of single-component primary care practice-based interventions and effect on cancer screening participation

First author, year, country Practice-focused intervention category Cancer Comparator Follow-up period (month/s) Effect measure Findings* and estimates Contextual
factor(s)
Quality score – rating
Single-component RCTs
Aubin-Auger, 2016, France Training Bowel Usual care 7 Intervention group versus Control group No effect
36.7% versus 24.5%, P  = 0.03
n/a 22 – good
Dignan, 2014, US Training Bowel Delayed intervention 6 Intervention group versus Control group No effect
79.7% versus 71.2%, P  = 0.06
n/a 19 – fair
Wang, 2018, US Training Bowel Usual care 6 Intervention group versus Control group No effect
24.4% versus 17.7%, P  = 0.24
n/a 24 – good
Guiriguet, 2016, Spain Reminders Bowel Usual care 12 Intervention group versus Control group No effect
44.1% versus 42.2%, P  = 0.1466
n/a 23 – good
Rat, 2017, France Patient-specific reminders Bowel Usual care 12 Difference between trial arms Positive effect
4.2% (95% CI, 2.3 to 6.2), P < 0.001)
n/a 21 – good
Patient-specific reminders Generic reminders Positive effect
3.1% (95% CI, 1.3 to 5.0), P < 0.001
Generic reminders Usual care No effect
1.1% (95% CI, −0.6 to 2.8), P < 0.21)
Hwang, 2019, US Audit and feedback – practice target Bowel Baseline 12 Pre-Post Positive effect
64.6% to 72.5%, P < 0.01
n/a 21 – good
Audit and feedback -practice target Cervical Positive effect
65.30% to 77%, P < 0.01
Vaisson, 2019, Canada Behavior change technique – anticipated regret influencing use of an audit and feedback tool Bowel Usual care 13 Rate ratio No effect
1 (95% CI, 0.998 to 1.002), P  = 0.99
n/a 25 – good
Behavior change technique – material incentive influencing use of an audit and feedback tool Bowel No effect
1 (95% CI, 0.998 to 1.002), P  = 0.93
Behavior change technique – problem-solving influencing use of an audit and feedback tool Bowel No effect
1 (95% CI, 0.998 to 1.002), P  = 0.95
Behavior change technique – anticipated regret influencing use of an audit and feedback tool Breast No effect
1 (95% CI, 0.997 to 1.002), P  = 0.81
Behavior change technique – material incentive influencing use of an audit and feedback tool Breast No effect
1 (95% CI, 0.997 to 1.003), P  = 0.94
Behavior change technique – problem-solving influencing use of an audit and feedback tool Breast No effect
0.998 (95% CI, 0.995 to 1.001), P  = 0.13
Behavior change technique – anticipated regret influencing use of an audit and feedback tool Cervical No effect
1.002 (95% CI, 0.998 to 1.003), P  = 0.83
Behavior change technique – material incentive influencing use of an audit and feedback tool Cervical No effect
1 (95% CI, 0.998 to 1.002), P  = 0.81
Behavior change technique – problem-solving influencing use of an audit and feedback tool Cervical Positive effect
1.003 (95% CI, 1.001 to 1.006), P  = 0.003
Single-component non-randomized trials
Greene, 2013, Australia Financial incentive Cervical Baseline n/a Mixed-method evaluation No effect
5% increase – not sustained
n/a 16 – fair
Kiran, 2014, Canada Financial incentives Bowel Baseline 12 Step change after introduction of incentives No effect
0.95 (95% CI, −2.2 to 4.1)
n/a 19 – fair
Breast No effect
1.6 (95% CI, −0.25 to 3.4)
Cervical No effect
1.5 (95% CI, −0.80 to 3.8)
Kirschner, 2013, Netherlands Financial incentive Cervical Baseline 12 Pre-Post No effect
71.90% to 72.50%
n/a 18 – fair
Gavagan, 2010, US Financial incentive Breast Non-incentivized clinics 18 Linear mixed model No effect
Slope: 0.003 versus 0.0015, P = 0.076
n/a 17 – fair
Cervical No effect
Slope: 0.005 versus −0.004, P = 0.053
Jung, 2017, US Financial incentive – adopting/using EHR Bowel Non-incentivised family physicians 12 Odds ratio Positive effect
1.2 (95% CI, 1.1 to 1.4)
n/a 18 – fair
Curry, 2011, US Education Bowel Baseline 6 Pre-Post No effect
56% to 60%, P  = 0.29
n/a 16 – fair
Hsiang, 2019, US Reminders Bowel Control practices 12 Change in patient completion of screening No effect
1.0 percentage points (95% CI, −3.2 to 4.6 percentage points)
n/a 19 – fair
Breast No effect
0.1 percentage points (95% CI, −4.0 to 4.3 percentage points)
Jonah, 2017, Canada Audit and feedback Bowel – due for screening Control family physicians 5 Odds ratio Positive effect
1.08 (95% CI, 1.05 to 1.12)
n/a 18 – fair
Bowel – overdue for screening Positive effect
1.15 (95% CI, 1.12 to 1.19)
Breast- due for screening No effect
0.98 (95% CI, 0.96 to 1.01)
Breast – overdue for screening Positive effect
1.06 (95% CI, 1.04 to 1.09)
Cervical – due and overdue for screening Positive effect
1.09 (95% CI, 1.07 to 1.12)
*

No effect refers to no statistically significant effect of the intervention.

Training and/or education

Three cluster RCTs assessed whether training and/or education for PHCWs increased bowel cancer screening participation. Aubin-Auger et al. (2016) assessed the effect of training focused on improving GPs’ communication skills, Dignan et al. (2014) investigated whether more comprehensive PHCW-focused training and education on the following topics – screening efficacy, clinical performance measures, patient counseling, and creating a screening-friendly environment increased participation, and Wang et al. (2018) tested whether training family physicians on patient-centered communication had an impact. None of these trials increased screening participation compared to usual care.

Provider reminders

Two cluster RCTs assessed whether provider reminders could increase bowel screening participation. Guiriguet and Castells (2016) evaluated the effect of an alert in electronic medical records for first-time screeners, finding no effect on screening rate when compared to the control group. Conversely, Rat et al. (2017) found providing GPs with a list of patients who were non-adherent to screening (patient-specific reminders) compared to usual care had a positive effect on screening rates. A positive effect on screening rates was also found when comparing patient-specific reminders to generic reminders; however, no effect was found when comparing generic reminders to usual care.

Audit and feedback

Two studies assessed the effect of audit and feedback on screening. Hwang et al. (2019) found an audit and feedback tool to have a positive effect on bowel and cervical screening rates compared to baseline. Vaisson et al. (2019) examined the effect of emails to providers that used behavior change techniques (either problem-solving, anticipated regret, or material incentive) to promote access to an existing audit and feedback tool. Among practitioners receiving problem-solving emails, there was a positive effect on cervical screening, but there was no effect on bowel or breast screening participation. Emails operationalizing anticipated regret and material incentives had no effect.

Single-component – non-randomized trials

Eight studies from the US (n  = 5), Australia (n  = 1), Netherlands (n  = 1), and Canada (n  = 1) were single-component non-randomized trials (Gavagan et al., 2010; Curry et al., 2011; Greene, 2013; Kirschner et al., 2013; Kiran et al., 2014; Jonah et al., 2017; Jung et al., 2017; Hsiang et al., 2019) (Table 2).

Financial incentives

Five studies assessed whether financial incentives to providers would increase screening participation of which three focused on pay-for-performance (P4P) programs. Greene (2013) examined the effect of paying GPs to conduct cervical screening for overdue women, Kiran et al. (2014) evaluated a P4P program with high uptake among family physicians, which offered substantial financial incentives to increase bowel, breast, and cervical screening, and Kirschner et al. (2013) assessed whether general practice receiving a bonus based on a score of patient care increased screening. None of these P4P programs had an impact on screening rates compared to baseline. Gavagan et al. (2010) found that doubling financial incentives related to achieving group targets on breast or cervical screening rates had no effect. In Jung et al. (2017), family physicians participated in an initiative where payments were received for adopting and using electronic health records (EHRs). Unlike the previous studies, a positive effect on bowel screening rates was found.

Education and training, provider reminders or audit and feedback

Three studies assessed the effect of education and training, provider reminders, or audit and feedback. Curry et al. (2011) examined an education and training intervention, finding no effect on bowel screening rates. Hsiang et al. (2019) assessed the effect of provider reminders, finding that although there was a large increase in clinician ordering of tests, there was no effect on screening rates for bowel and breast. Jonah et al. (2017) assessed an audit and feedback tool, finding a positive effect on screening rates among people due and overdue for bowel and cervical screening, and among patients overdue for breast screening. Among women due for breast screening, there was no change in screening rates.

Multi-component – RCTs

Twelve studies from the US (n  = 10), Australia (n  = 1), and Norway (n  = 1) were multi-component RCTs (Aragones et al., 2010; Ornstein et al., 2010; Atlas et al., 2011; Shaw et al., 2013; Atlas et al., 2014; Price-Haywood et al., 2014; Basch et al., 2015; Sun et al., 2018; Dodd et al., 2019; Cameron et al., 2020; Moen et al., 2020; Walsh et al., 2020) (Table 3).

Table 3.

Overview of multi-component primary care practice-based interventions and effect on cancer screening participation

First author, year, country Practice-focused
intervention
category
Patient-focused
intervention
category
Cancer Comparator Follow-up period (month/s) Effect measure Findings* and
estimates
Contextual
factor(s)
Quality score – rating
Multi-component RCTs
Price-Haywood, 2014, US Training n/a Bowel Audit and feedback 24 Intervention group (pre-post) versus Control group (pre-post) No effect
23.4% to 44% versus 35.1% to 63.2%
n/a 22 – good
Audit and feedback Breast Positive effect
22.3% to 43.3% versus 35.1% to 63.2%, P < 0.05
Cervical No effect
20.2% to 34.4% versus 33.7% to 56.7%
Shaw, 2013, US Practice-facilitated assessment and improvement n/a Bowel Control 12 Odds ratio No effect
1.17 (95 CI, 0.86 to 1.59, P  = 0.32
Whole-of-practice approach 24 – good
Education and training Practice champion
Ornstein, 2010, US Audit and feedback n/a Bowel Control 24 Difference between trial arms Positive effect
4.9% (95% CI, 3.6 to 6.1), P < 0.0001
Whole-of-practice approach 23 – good
Education and training
Aragones, 2010, US Reminder Promotional material Bowel Usual care 3 Odds ratio Positive effect
5.4 (95% CI, 1.6 to 18.5)
n/a 24 – good
Education
Moen, 2020, Norway Education Promotional material Cervical Usual care 6 Odds ratio Positive effect
1.24 (95% CI, 1.11 to 1.38)
n/a 20 – good
Reminder
Walsh, 2020, US Reminder Promotional material Bowel Usual care 14 Intervention group versus Control group No effect
17.9% versus 11.6%, P  = 0.31
n/a 21 – good
Breast No effect
4% versus 6.4%, P  = 0.48
Cervical No effect
10.7% versus 13.9%, P  = 0.89
Atlas, 2011, US Reminder Reminder Breast Usual care 12 Intervention group versus Control group Positive effect
31.4% versus 23.2%, P < 0.001
Whole-of-practice approach 21 – good
Patient navigation
Atlas, 2014, US Reminder Reminder Bowel Patients receiving reminder and transfer to practice delegate lists 12 Intervention group versus Control group No effect
77.8% versus 76.2%, P  = 0.33
Whole-of-practice approach 24 – good
Patient navigation Breast No effect
82.7% versus 82.7% P  = 0.96
Cervical No effect
84.1% versus 84.7%, P  = 0.6
Dodd, 2019, Australia Training Education Bowel Usual care 1.5 Odds ratio Positive effect
10.24 (95% CI, 2.9 to 36.6), P  = 0.0006
n/a 20 – good
Provision of screening kit
Sun 2018, US Education Education Bowel Usual care 12 Intervention group versus Control group Positive effect
58.5% versus 22.2%, P < 0.0001
n/a 17 – fair
Provision of screening kit
Letter of recommendation
Basch, 2015, US n/a Education Bowel Provider education 12 Difference between trial arms No effect
18.3% versus 20.0%, P  = 0.79
n/a 22 – good
Education n/a Provider education and patient education No effect
20% versus 25.6%, P  = 0.23
n/a Education Provider education and patient education No effect
18.3% versus 25.6%, P  = 0.11
Cameron, 2020, USA Education and training
Audit and feedback
Promotional material
Education
Bowel Usual care 6 Rate ratio No effect
1.65 (95% CI, 0.62 to 4.38, P  = 0.32)
n/a 23 – good
Education and training
Audit and feedback
n/a Patient promotional material and patient education No effect
0.80, (95% CI, 0.53 to 1.20, P  = 0.28)
Multi-component non-randomized trials
Ruggeri, 2020, US Practice-facilitated assessment and improvement Education Bowel Baseline 12 Pre-Post Positive effect n/a 15 – fair
Practice 1  = 32.3% to 45.4%
Provision of screening kit Practice 2  = 27.7% to 36.8%
Practice 3  = 23.2% to 47.9%
Education Reminder Practice 4  = 27.5% to 36.8%
Hills, 2015, US Practice-facilitated assessment and improvement Reminder Cervical Baseline 12 Pre-Post Positive effect
38.1% to 69.7%, P < 0.001
Whole-of-practice approach 16 – fair
Education Practice champion
Walker-Smith, 2020, US Practice-facilitated assessment and improvement n/a Breast Baseline 3 Pre-Post Positive effect
54.8% to 65.2%
n/a 17 – fair
Training
Frissora, 2021, US Practice-facilitated assessment and improvement Education Bowel Baseline 5 Pre-Post Positive effect
69.8% to 76%
n/a 16 – fair
Education
Audit and feedback
Desai, 2021, US Practice-facilitated assessment and improvement Education Bowel Baseline 3 Pre-Post Positive effect Practice champion 16 – fair
Practice 1  = 41% to 48.4%, P < 0.0001
Practice 2  = 31.6% to 37.8%, P < 0.0001
Practice 3  = 30.5% to 38.2%, P < 0.0001
Practice 4  = 43.9% to 46.8%, P  = 0.012
Hussain 2021, US Practice-facilitated assessment and improvement Promotional material Bowel Pre-intervention group n/a Post-Group versus Pre-Group Positive effect
74.4% (95% CI, 64.6 to 82.3) versus 31.1% (95% CI, 26.2 to 36.6, P < 0.001
Whole-of-practice approach 18 – fair
Training Reminders
Weiner, 2017, USA Practice-facilitated assessment and improvement Provision of screening kit Bowel Baseline 12 Pre-Post Positive effect
23.0% to 34.0%, P  = 0.03
Whole-of-practice approach 17 – good
Practice champion
Reminder
Financial incentive
Mader, 2016, US Practice-facilitated assessment and improvement n/a Bowel Baseline 6 Pre-Post Positive effect
32.74% to 38.3%, P < 0.001
Whole-of-practice approach 17 – fair
Education Breast Positive effect
36.96% to 49.96%, P < 0.001
Practice champion
Cervical Negative effect
35.65% to 38.95%, P  = 0.998
Jones 2022, US Practice-facilitated assessment and improvement
Audit and feedback
Reminders Bowel Pre-intervention group 12 Prevalence ratio Positive effect
1.85 (95% CI, 91.63 to 2.11), P < 0.05
Whole-of-practice approach 19 – fair
Breast No effect
1.11 (95% CI, 0.98 to 1.27), P  > 0.05
Practice champion
Cervical Positive effect
1.44 (95% CI, 1.18 to 1.76), P < 0.05
Nguyen, 2020, US Practice-facilitated assessment and improvement
Education
Financial incentives
n/a Bowel Pre-intervention group 24 Difference-in-differences No effect
−0.2 (−1.64, 1.62), P  = .99
Whole-of-practice approach 15 – fair
Breast No effect
1.80 (−0.87, 4.47), P  = .18
Cervical No effect
−2.56 (−5.44, 0.31), P  = 0.08
Harris, 2015, Canada Practice-facilitated assessment and improvement
Education and training
Education Bowel Control 24 Intervention group versus Control group No effect
66.1% versus 61.7%, P  = 0.77
Whole-of-practice approach 20 – good
Green, 2017, Canada Practice-facilitated assessment and improvement
Education and training
Education Bowel Baseline 12–24 Difference between trial arms Positive effect
5.4% (95% CI, 3.1 to 7.8)
n/a 20 – good
Cervical Positive effect
2.7% (95% CI 0.9 to 4.6)
Marx, 2016, US Practice-facilitated assessment and improvement
Audit and feedback
Education and training
Financial incentives
Education
Reminders
Bowel Baseline n/a Change in screening prevalence Positive effect
1.1% to 14.5%
(3 clinics)
n/a 16 – fair
Dorrington, 2015, Australia Practice-facilitated assessment and improvement Promotional material Cervical Baseline 10 t-tests Positive effect
t(50)   = −3.221, P  = 0.002
n/a 18 – fair
Education
Hountz, 2017, US Practice-facilitated assessment and improvement Promotional material Bowel Baseline 11 Pre-post Positive effect
30% to 58%, P < 0.001
Whole-of-practice approach 16 – fair
Reminders
Bakhai, 2018, US Practice-facilitated assessment and improvement Patient navigation Bowel Baseline 6 Pre-post Positive effect
50% to 75%
Whole-of-practice approach 16 – fair
Reminder Education Practice champion
Education Financial incentive
Baxter, 2017, Canada 4–5 components, including – Reminder n/a Bowel 0–1 practice-focused components 24 Hazard ratio Positive effect
1.27 (95% CI, 1.16 to 1.39, P < 0.0001)
n/a 19 – fair
Audit and feedback
Potter, 2011, US Education and training Education Bowel Usual care 12 Difference between trial arms Positive effect
18% versus 1.7%, P < 0. 001
n/a 16 – fair
Provision of screening kit
Funes, 2021, US Education and training Reminder Bowel Usual care 12 Odds ratio Positive effective
2.4 (95% CI, 1.6 to 2.6), P  = .001
n/a 16 – fair
Provision of screening kit
Wu, 2016, US Reminder Reminder Bowel Usual care 5 Intervention group versus control group Positive effect
81.0% versus 78.1%, P < 0.05
Whole-of-practice approach 17 – fair
Education Practice champion
Patient navigation
Willemse, 2022, US Education Education Bowel Baseline 5 Pre-post Positive effect
45.8% to 65.4%
n/a 15 – fair
Reminder
Provision of screening kit
Kaczorowski, 2013, Canada Financial incentives Reminder Breast Baseline 2 Pre-post (difference in screening rates) Positive effect
6.3% (P < 0.001)
n/a 18 – fair
Reminder Cervical Positive effect
5.3% (P < 0.001)
*

No effect refers to no statistically significant effect of the intervention.

Practitioner-focused intervention components

Three studies assessed the effect of interventions with multiple practitioner-focused components on screening rates. Price-Haywood et al. (2014) looked at whether training family physicians on how to engage in cancer risk communication, in addition to audit and feedback, would increase screening. When compared to audit-only, there was a positive effect on breast screening, but no effect on bowel and cervical screening rates. Shaw et al. (2013) found no effect on bowel screening rates when comparing practices participating in practice-facilitated assessment and improvement and education and training to control practices. However, Ornstein et al. (2010) found a positive effect on bowel screening rates when assessing the impact of audit and feedback and education and training compared to control practices.

Provider reminders and patient promotional material

Three studies evaluated the effect of interventions involving provider reminders and patient promotional material in the waiting room compared to usual care. In Aragones et al. (2010), patients watched a bowel screening video and received a brochure summarizing the video’s messages. They were also given a reminder to hand it to their family physician. A positive effect on bowel screening rates was found. Similarly, Moen et al. (2020) found a positive effect on cervical screening rates following an educational session for GPs, provider reminders, and promotional material in the form of a poster. Walsh et al. (2020) assessed the effect of promotional material, in the form of a virtual ‘Doctor’ and provider reminders. However, unlike Aragones et al. (2010) and Moen et al. (2020), no effects on bowel, breast, or cervical screening rates were found.

Audit and feedback, patient reminders, and patient navigation

Two studies assessed the effect of audit and feedback, patient reminders, and patient navigation. Atlas et al. (2011) evaluated the use of an informatics system, which connected overdue patients to appropriate providers and presented providers with a list of their overdue patients. Patients received reminders and navigation. A positive effect on breast screening rates was found when compared to usual care. More recently Atlas et al. (2014) studied the impact of involving family physicians in a web-based IT application, with physicians in the intervention arm receiving a list of their overdue patients and providing individualized outreach – via a letter, practice delegate, or practice navigator. However, in comparison to the control, where overdue patients were automatically sent reminder letters and transferred to patient delegate lists, no effect on bowel, breast, or cervical screening rates was found.

Practitioner-focused and patient-focused intervention components

Two studies assessed the effect of interventions comprising different combinations of practitioner-focused and patient-focused components, with both studies including patient education and provision of a bowel cancer screening kit at point-of-care. Dodd et al. (2019) assessed the effect of providing GPs with a script to assist them in endorsing screening and providing patients with a screening kit and education. Similarly, in Sun et al. (2018), family physicians received education and patients received education, a screening kit, and a letter of recommendation from their physician. Both studies reported a positive effect on bowel screening rates.

Difference between practitioner-focused and/or patient-focused intervention components

Two studies assessed whether there was a difference between intervention groups in screening rates. Basch et al. (2015) compared screening rates between – 1. patients receiving educational material, 2. family physicians receiving education, and 3. family physicians receiving education and patients also receiving education. Cameron et al. (2020) compared bowel screening rates between – 1. Physicians receiving education and audit and feedback and patients watching an educational video, 2. Physicians receiving education and audit and feedback, and 3. Usual care. No effect on bowel screening rates was found for either study.

Multi-component – non-randomized trials

Twenty-two studies from the US (n  = 18), Canada (n  = 3) and Australia (n  = 1) were multi-component non-randomized trials (Potter et al., 2011; Kaczorowski et al., 2013; Dorrington et al., 2015; Harris et al., 2015; Hills et al., 2015; Mader et al., 2016; Marx et al., 2016; Wu et al., 2016; Baxter et al., 2017; Green et al., 2017; Hountz et al., 2017; Weiner et al., 2017; Bakhai et al., 2018; Nguyen et al., 2020; Desai et al., 2021; Funes et al., 2021; Frissora et al., 2021; Hussain et al., 2021; Jones et al., 2022; Ruggeri et al., 2020; Walker-Smith and Baldwin, 2020; Willemse et al., 2022) (Table 3).

The effect of practice-facilitated assessment and improvement, in the form of Quality Improvement (QI) projects and Plan-Do-Study-Act (PDSA) cycles was assessed by sixteen studies. QI projects apply a systematic approach to design, test, and implement interventions (Jones et al., 2019). PDSA cycles are commonly used in QI projects and provide a structured approach to testing interventions and making appropriate adjustments to increase the likelihood of the intervention delivering its’ desired effect.

QI projects

Ten practice-facilitated assessment and improvement studies looked at the effect of a QI project on screening. Ruggeri et al. (2020) assessed the effect of provider education, patient education, provision of screening kit, and patient reminders. Like Ruggeri et al. (2020), Hills et al. (2015) reported a positive effect on cervical screening rates following the implementation of a clinical decision support system, provider education, and patient reminders. Walker-Smith and Baldwin (2020) found a positive effect on breast screening following training practice staff to implement screening tools. Frissora et al. (2021) looked at the impact of educating and training providers on screening modalities, educating patients, and audit and feedback, Desai et al. (2021) assessed the effect of provider education and patient education, and Hussain et al. (2021) assessed the impact of provider training, promotional material in the form of a poster, and patient reminder letters. Weiner et al. (2017) looked at the effect of a practice facilitator supporting the implementation of office systems, such as screening reminders. Participating practices also received a financial incentive and screening kits to disseminate. All studies had a positive effect on bowel screening participation. Mader et al. (2016) evaluated whether education followed by practice-facilitated assessment and improvement, whereby practices worked with QI professionals to conduct activities such as reminder systems streamlining, would increase screening rates. When compared to baseline, a positive effect on bowel screening and breast screening was found, but no effect was found on cervical screening rates. Jones et al. (2022) evaluated the effect of audit and feedback and patient reminders on screening rates, finding a positive effect for bowel and cervical; however, no effect for breast. Contrary to the previous practice-facilitated and assessment studies, Nguyen et al. (2020) found no effect on bowel, breast, and cervical screening rates when assessing the effect of provider education and financial incentives.

Large-scale QI projects

Three studies provided an overview of large-scale QI projects. The QI program utilized PDSA methodology and included components such as provider education and training, and patient education. On a practitioner level, Harris et al. (2015) found no effect on bowel screening rates. However, a supplementary population-level study by Green et al. (2017) found a positive effect on bowel screening and cervical screening. Marx et al. (2016) assessed the effect of a continuous QI project to increase bowel screening rates at five clinics, with components including audit and feedback, provider education and training, provider financial incentives, patient education, and patient reminders. A continuous positive effect was found in three of the five clinics.

PDSA cycles

Three studies assessed the effect of PDSA cycles, involving practitioner-focused and patient-focused intervention components. Dorrington et al. (2015) used rapid PDSA cycles to implement interventions including education to wider practice-team members and promotional material. A positive effect on cervical screening rates was found. Hountz et al. (2017) implemented reminders to nurses, promotional material, and simplified FOBT ordering processes, and Bakhai et al. (2018) outlined the effect of eight PDSA cycles, with cycles including interventions such as provider reminders, patient navigation, and patient education. Both studies had a positive effect on bowel screening rates.

Practitioner-focused intervention components

Baxter et al. (2017) evaluated the impact of strategies on bowel screening uptake, finding practices that employed 4–5 strategies, such as provider reminders and audits and feedback, had a positive effect on bowel screening rates when compared to practices that employed 0–1 strategies.

Practitioner-focused and patient-focused intervention components

Five studies involved interventions comprising different combinations of practitioner-focused and patient-focused components. Potter et al. (2011) and Funes et al. (2021) adapted the FLU-FOBT program. Nurses received education and training on the program, and patients were provided with a screening kit, received education on bowel screening, or a reminder to screen. Wu et al. (2016) assessed the effect of an intervention whereby doctors reviewed rosters of patients due for bowel screening and chose practice delegate outreach or default reminder letter. Patients who were referred to the delegate received education about bowel screening and if they declined to undergo colonoscopy, they were facilitated with ordering a FOBT screening kit. In Willemse et al. (2022), practice staff received education on the importance of bowel screening and the available options for screening. Patients also received education, along with provider reminders and a screening kit. Kaczorowski et al. (2013) assessed the effect on breast and cervical screening rates when combining P4P incentives, provider reminders, and patient reminders. A positive effect was found for all five interventions.

Contextual factors of interventions

Multi-component studies outlined circumstances under which interventions were more likely to optimize the role of PHCWs and increase participation in screening programs through the use of two strategies: engaging whole teams in a practice setting and the use of champions (Tables 2 and 3). The ‘whole-of-practice approach’ contextual factor is defined as empowering an array of practice staff (eg, administrative staff, nurses, managers, and family physicians) to be involved in cancer screening interventions (Ornstein et al., 2010; Atlas et al., 2011; Shaw et al., 2013; Atlas et al., 2014; Harris et al., 2015; Hills et al., 2015; Mader et al., 2016; Wu et al., 2016; Hountz et al., 2017; Weiner et al., 2017; Bakhai et al., 2018; Nguyen et al., 2020; Hussain et al., 2021; Jones et al., 2022). Ornstein et al. (2010) concluded that practices that ‘meet as a team to plan evidence-based (quality) improvement strategies…can achieve much higher levels of screening than typically reported.’ Additionally, a multi-site study by Mader et al. (2016) discussed how practices with the greatest change in cancer screening rates ‘had fully engaged staff at several levels within the practice.’ Another contextual factor commonly reported was having a ‘practice champion’ to drive activities within screening programs (Shaw et al., 2013; Hills et al., 2015; Mader et al., 2016; Wu et al., 2016; Weiner et al., 2017; Bakhai et al., 2018; Desai et al., 2021; Jones et al., 2022). Hills et al. (2015) reported nearly doubling cervical screening rates (38.1% to 69.7%) following the selection of a practice nurse to facilitate and provide clear direction for a QI project. Similarly, Bakhai et al. (2018) outlined that ‘engaged (practice) leadership’ implementing a QI project exceeded their aim of increasing bowel screening rates from a baseline of 50% to 70%, reaching 75%.

Discussion

This systematic review of 49 studies targeting primary care practices has several key findings as an avenue to increase participation in cancer screening programs. Firstly, interventions with a positive effect were predominantly multi-component, and most included combinations of strategies such as audit and feedback, provider reminders, practice-facilitated assessment and improvement, and patient education across all screening programs. Regarding bowel screening, the provision of screening kits at point-of-care was an effective strategy to increase participation. Secondly, evidence to support the effectiveness of financial incentives for providers was limited, with the review finding most studies to have no effect on screening rates. Finally, ‘whole-of-practice approaches’ and identifying ‘practice champions’ were found to be contextual factors of effective interventions. This study provides novel understanding of components and contextual factors that should be included in interventions using PHCWs to facilitate greater participation in screening programs.

The findings suggest that complex interventions comprised of practitioner-focused and patient-focused components are required to increase cancer screening participation in primary care settings. Supporting the findings of previous research (Emery et al., 2014; Chauhan et al., 2017), audit and feedback were the only intervention components that had a positive effect on cancer screening rates across single-component and multi-component studies. By drawing attention to gaps in performance, audit and feedback likely act as a motivator for PHCWs to change the way they engage with screening programs (Thomson O’Brien et al., 2000). Of the 17 multi-component interventions assessing the effect of practice-facilitated assessments and improvements, fourteen studies reported a positive effect on screening participation rates. Practice-facilitated assessment and improvement may be effective due to being tailored to the needs of the practice, and therefore being more acceptable and appropriate. Existing research suggests provider reminders can increase PHCW’s engagement in cancer screening programs (Emery et al., 2012). Whilst we found provider reminders were often a component of multi-component interventions with a positive effect on screening rates, provider reminders as a single-component intervention did not always have a positive effect on screening rates.

Patient-focused components of interventions were identified as improving the ability of PHCWs to facilitate participation in cancer screening. The benefit of this approach is that it targets different barriers to change (Grimshaw et al., 2001), possibly explaining why provider reminders as a single-component intervention were less effective at increasing screening participation than when incorporated within a multi-component intervention. This is exemplified by Hsiang et al. (2019) who found that although provider reminders resulted in a large increase in clinician ordering of tests, there was no effect on bowel and breast screening rates.

Regarding bowel screening, patient education and the provision of a screening kit at point-of-care were common components of effective multi-component interventions. Educating patients before their appointment likely mitigates patient-level barriers to screening, including worry about the procedure or outcome (Ferdous et al., 2018; Suwankhong and Liamputtong, 2018; Muthukrishnan et al., 2019). Additionally, a practitioner providing a bowel cancer screening kit at point-of-care may mitigate structural barriers, such as time (Suwankhong and Liamputtong, 2018; Muthukrishnan et al., 2019), and demonstrates direct endorsement by a PHCW, an important facilitator in a patient’s decision to screen (Duffy et al., 2017). The importance of mitigating structural barriers to screening is highlighted by Potter et al. (2011) and Funes et al. (2021) who reported a positive effect on bowel screening rates for patients participating in the FLU-FOBT program when compared to non-recipients. A follow-up study by Potter et al. (2011) found components of the program and screening rates were maintained one year later (Walsh et al., 2012). Further supporting the importance of making it easier for patients to screen, mailing self-sampling cervical screening kits is more effective at reaching under-screened patients than sending an invitation or reminder letters for clinician sampling (Arbyn et al., 2018; Yeh et al., 2019).

Practitioner-focused financial incentives did not optimize the role of PHCWs, with single-component non-randomized trials reporting no effect on screening participation. However, Jung et al. (2017) did find that financial incentives for adopting and using EHRs had a positive effect on screening rates. The difference in these results may be due to financial incentives for engaging patients failing to consider the demanding setting in which PHCWs work, where they are faced with a plethora of competing health issues (Wender, 1993). EHRs facilitate the delivery of care for PHCWs by improving the organization and accessibility of clinical information.

Lastly, our review identified circumstances under which interventions were more likely to optimize the role of PHCWs and increase participation in screening programs. A whole-of-practice approach is likely an effective contextual factor due to spreading practice workload, with ‘time’ a known barrier to PHCWs engaging in cancer screening (Wender, 1993; Yarnall et al., 2003; Verbunt et al., 2022). A whole-of-practice approach is supported by a previous review (Chauhan et al., 2017), which outlined the importance of collaborative team-based interventions to effectively modify PHCW practice and patient outcomes. Having a practice champion to drive cancer screening interventions may also be an important contextual factor due to their role in promoting positive practice culture toward cancer screening programs (Verbunt et al., 2022).

Limitations

Interventions and study designs were heterogeneous, precluding meta-analysis. It was not possible to present data in forest plots due to the methodological heterogeneity, as well as some studies not reporting P-values or confidence intervals. However, our broad inclusion criteria for primary care practice-based interventions and study type (RCTs, non-randomized trials) ensured we captured the range of studies relevant to the topic, which in turn supports the relevance of findings for policy and planning. It is possible that contextual factors relevant to the outcomes were not all described in the original study reports, and have therefore not been acknowledged in this review. Our review only reports on contextual factors that were explicitly outlined in studies surrounding primary care practice-based interventions, with the potential that more implicit contextual factors were missed. Studies were predominantly from the US, and the majority were focused on bowel cancer screening, with findings potentially not generalizable to countries where the structure of the screening program differs.

Conclusions

Multi-component interventions that are tailored to the needs of a primary care setting, and the patients they serve, may improve the ability of PHCWs to facilitate greater participation in population-based cancer screening programs. Future research should explore the effect of combining identified components of effective interventions (audit and feedback, provider reminders, practice-facilitated assessment and improvement, and patient education across all screening programs and the provision of screening kits at point-of-care for bowel screening) with contextual factors (whole-of-practice approach, practice champion) to maximize screening participation

Supporting information

Verbunt et al. supplementary material 1

Verbunt et al. supplementary material

Verbunt et al. supplementary material 2

Verbunt et al. supplementary material

Acknowledgments

We thank Jim Berryman, Liaison Librarian, Brownless Biomedical Library University of Melbourne for his expert input when developing the search strategy. We dedicate this study to the memory of Professor Margaret Kelaher.

Note

1.

The term ‘family physician’ is used to refer to studies conducted in the US and Canada and ‘general practitioners (GPs)’ for studies conducted in all other countries.

Supplementary material

To view supplementary material for this article, please visit https://doi.org/10.1017/S1463423623000713

Financial support

This work was supported by the Commonwealth Department of Health, Australia. The funder had no role in the design, execution, analyses, interpretation, and decision to publish.

Competing interests

None.

Ethical standards

Ethics committee approval was not required for this review.

References

  1. Aragones A, Schwartz MD, Shah NR and Gany FM (2010) A randomized controlled trial of a multilevel intervention to increase colorectal cancer screening among Latino immigrants in a primary care facility. Journal of General Internal Medicine 25, 564–567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arbyn M, Smith SB, Temin S, Sultana F, Castle P, Collaboration on, S.-S. & Testing, H. P. V. (2018) Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses. British Medical Journal 363, k4823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Atlas SJ, Grant RW, Lester WT, Ashburner JM, Chang Y, Barry MJ and Chueh HC (2011) A cluster-randomized trial of a primary care informatics-based system for breast cancer screening. Journal of General Internal Medicine 26, 154–161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Atlas SJ, Zai AH, Ashburner JM, Chang Y, Percac-Lima S, Levy DE, Chueh HC and Grant RW (2014) Non-visit-based cancer screening using a novel population management system. Journal of the American Board of Family Medicine 27, 474–485. [DOI] [PubMed] [Google Scholar]
  5. Aubin-Auger I, Laouenan C, Le Bel J, Mercier A, Baruch D, Lebeau JP, Youssefian A, Le Trung T, Peremans L and Van Royen P (2016) Efficacy of communication skills training on colorectal cancer screening by GPs: a cluster randomised controlled trial. E European Journal of Cancer Care (England) 25, 18–26. [DOI] [PubMed] [Google Scholar]
  6. Australian Government Department of Health (2021. a) National bowel cancer screening program [Online]. Retrieved July 7 2021 from https://www.health.gov.au/initiatives-and-programs/national-bowel-cancer-screening-program
  7. Australian Government Department of Health (2021. b) National cervical screening program [Online]. Retrieved July 7 2021 from https://www.health.gov.au/initiatives-and-programs/national-cervical-screening-program
  8. Australian Instititute of Health and Welfare (2020) National bowel cancer screening program: monitoring report 2020. Canberra: AIHW. [Google Scholar]
  9. Babineau J (2014) Product review: covidence (systematic review software). Journal of the Canadian Health Libraries Association 35, 68–71. [Google Scholar]
  10. Bakhai S, Ahluwalia G, Nallapeta N, Mangat A and Reynolds JL (2018) Faecal immunochemical testing implementation to increase colorectal cancer screening in primary care. BMJ Open Quality 7, e000400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Basch CE, Zybert P, Wolf RL, Basch CH, Ullman R, Shmukler C, King F, Neugut AI and Shea S (2015) A randomized trial to compare alternative educational interventions to increase colorectal cancer screening in a hard-to-reach urban minority population with health insurance. Journal of Community Health 40, 975–983. [DOI] [PubMed] [Google Scholar]
  12. Baxter NN, Sutradhar R, Li Q, Daly C, Honein-Abouhaidar GN, Richardson DP, Del Giudice L, Tinmouth J, Paszat L and Rabeneck L (2017) Do primary care provider strategies improve patient participation in colorectal cancer screening? (vol 112, pg 974, 2017). American Journal of Gastroenterology 112, 974–974. [DOI] [PubMed] [Google Scholar]
  13. Boudioni M, Mossman J, Jones AL, Leydon G and McPherson K (1998) Celebrity’s death from cancer resulted in increased calls to CancerBACUP. British Medical Journal 317, 1016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Cameron KA, Ramirez-Zohfeld V, Ferreira MR, Dolan NC, Radosta J, Galanter WL, Eder MM, Wolf MS and Rademaker AW (2020) The effects of a multicomponent colorectal cancer screening intervention on knowledge, recommendation, and screening among underserved populations. Journal of Health Care for the Poor and Underserved 31, 1612–1633. [DOI] [PubMed] [Google Scholar]
  15. Canadian Task Force on Preventive Health, C. (2001) Colorectal cancer screening. Recommendation statement from the Canadian Task Force on Preventive Health Care. Canadian Medical Association Journal 165, 206–208. [PMC free article] [PubMed] [Google Scholar]
  16. Chapman S, McLeod K, Wakefield M and Holding S (2005) Impact of news of celebrity illness on breast cancer screening: kylie Minogue’s breast cancer diagnosis. Medical Journal of Australia 183, 247–250. [DOI] [PubMed] [Google Scholar]
  17. Chauhan BF, Jeyaraman MM, Mann AS, Lys J, Skidmore B, Sibley KM, Abou-Setta AM and Zarychanski R (2017) Behavior change interventions and policies influencing primary healthcare professionals’ practice-an overview of reviews (vol 12, 3, 2017). Implementation Science 12, 1–16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Craig P, Di Ruggiero E, Frohlich K, MyKhalovskiy E, White M and On Behalf of the Canadian Institutes of Health Research (CIHR)–National Institute for Health Research (NIHR) Context Guidance Authors Group (2018) Taking account of context in population health intervention research: guidance for producers, users and funders of research. Southampton: NHR Evaluation, Trials and Studies Coordinating Centre. [Google Scholar]
  19. Curry WJ, Lengerich EJ, Kluhsman BC, Graybill MA, Liao JZ, Schaefer EW, Spleen AM and Dignan MB (2011) Academic detailing to increase colorectal cancer screening by primary care practices in Appalachian Pennsylvania. BMC Health Service Research 11, 112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Desai K, Mehta M and Vega KJ (2021) Effect of a physician led education invention on colon cancer screening at underserved clinics in Georgia. Patient Education and Counseling 104, 1494–1496. [DOI] [PubMed] [Google Scholar]
  21. Dignan M, Shelton B, Slone SA, Tolle C, Mohammad S, Schoenberg N, Pearce K, Van Meter E and Ely G (2014) Effectiveness of a primary care practice intervention for increasing colorectal cancer screening in Appalachian Kentucky. Preventive Medicine 58, 70–74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Dodd N, Carey M, Mansfield E, Oldmeadow C and Evans TJ (2019) Testing the effectiveness of a general practice intervention to improve uptake of colorectal cancer screening: a randomised controlled trial. Australian and New Zealand Journal of Public Health 43, 464–469. [DOI] [PubMed] [Google Scholar]
  23. Dorrington MS, Herceg A, Douglas K, Tongs J and Bookallil M (2015) Increasing Pap smear rates at an urban Aboriginal Community Controlled Health Service through translational research and continuous quality improvement. Australian Journal of Primary Health 21, 417–422. [DOI] [PubMed] [Google Scholar]
  24. Downs SH and Black N (1998) The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. Journal of Epidemiology and Community Health 52, 377–384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Duffy SW, Myles JP, Maroni R and Mohammad A (2017) Rapid review of evaluation of interventions to improve participation in cancer screening services. Journal of Medical Screen 24, 127–145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Durkin SJ, Broun K, Spittal MJ and Wakefield MA (2019) Impact of a mass media campaign on participation rates in a National Bowel Cancer Screening Program: a field experiment. BMJ Open 9, e024267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Emery J, Trevena L, Mazza D, Fallon-Ferguson J, Shaw K, Williams B and Varlow M (2012) The role of primary and community-based healthcare professionals in early detection and follow-up in cancer care – a rapid review of best practice models: an Evidence Check rapid review brokered by the Sax Institute for the Cancer Institute NSW, Australia: Sax Institute.
  28. Emery JD, Shaw K, Williams B, Mazza D, Fallon-Ferguson J, Varlow M and Trevena LJ (2014) The role of primary care in early detection and follow-up of cancer. Nature Reviwes Clinical Oncology 11, 38–48. [DOI] [PubMed] [Google Scholar]
  29. Ferdous M, Lee S, Goopy S, Yang H, Rumana N, Abedin T and Turin TC (2018) Barriers to cervical cancer screening faced by immigrant women in Canada: a systematic scoping review. BMC Womens Health 18, 165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Fontham ETH, Wolf AMD, Church TR, Etzioni R, Flowers CR, Herzig A, Guerra CE, Oeffinger KC, Shih YT, Walter LC, Kim JJ, Andrews KS, Desantis CE, Fedewa SA, Manassaram-Baptiste D, Saslow D, Wender RC and Smith RA (2020) Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA Cancer Journal of Clinical 70, 321–346. [DOI] [PubMed] [Google Scholar]
  31. Force USPST, Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW Jr, Garcia FAR, Gillman MW, Harper DM, Kemper AR, Krist AH, Kurth AE, Landefeld CS, Mangione CM, Owens DK, Phillips WR, Phipps MG, Pignone MP and Siu AL (2016) Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. Journal of the American Medical Association 315, 2564–2575. [DOI] [PubMed] [Google Scholar]
  32. Frissora KD, Biernacki PJ and Walloch J (2021) Increasing awareness of screening methods for colorectal cancer improves outcomes. Journal for Nurse Practitioners 17, 697–701. [Google Scholar]
  33. Funes SA, Flores C, Davidow AL, Friedman S, Korenblit P and Thomas P (2021) Adaptation of the Flu-FIT program for patient-aligned care teams: a quality improvement project. Journal of Public Health Management & Practice 27, S159–S163. [DOI] [PubMed] [Google Scholar]
  34. Gavagan TF, Du H, Saver BG, Adams GJ, Graham DM, McCray R and Goodrick GK (2010) Effect of financial incentives on improvement in medical quality indicators for primary care. Journal of American Board of Family Medicine 23, 622–631. [DOI] [PubMed] [Google Scholar]
  35. Green ME, Harris SB, Webster-Bogaert S, Han H, Kotecha J, Kopp A, Ho MM, Birtwhistle RV and Glazier RH (2017) Impact of a provincial quality-improvement program on primary health care in Ontario: a population-based controlled before-and-after study. CMAJ Open 5, E281–E289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Greene J (2013) An examination of pay-for-performance in general practice in Australia. Health Service Research 48, 1415–1432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Grimshaw JM, Shirran L, Thomas R, Mowatt G, Fraser C, Bero L, Grilli R, Harvey E, Oxman A and O’Brien MA (2001) Changing provider behavior: an overview of systematic reviews of interventions. Medical Care 39, II2–45. [PubMed] [Google Scholar]
  38. Guiriguet C and Castells A (2016) Alerts in electronic medical records in primary care to promote colorectal cancer screening. British Journal of General Practice 66, 513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Hand E (2020) Jahresbericht evaluation: Deutsches Mammographie-screening-programme. Berlin, Germany: Kooperationsgemeinschaft Mammographie [Google Scholar]
  40. Harris SB, Green ME, Brown JB, Roberts S, Russell G, Fournie M, Webster-Bogaert S, Paquette-Warren J, Kotecha J, Han H, Thind A, Stewart M, Reichert S, Tompkins JW and Birtwhistle R (2015) Impact of a quality improvement program on primary healthcare in Canada: a mixed-method evaluation. Health Policy 119, 405–416. [DOI] [PubMed] [Google Scholar]
  41. Hills RL, Kulbok PA and Clark M (2015) Evaluating a quality improvement program for cervical cancer screening at an urban safety net clinic. Health Promotion Practice 16, 631–641. [DOI] [PubMed] [Google Scholar]
  42. Hooper P, Jutai JW, Strong G and Russell-Minda E (2008) Age-related macular degeneration and low-vision rehabilitation: a systematic review. Canadian Journal of Ophthalmology 43, 180–187. [DOI] [PubMed] [Google Scholar]
  43. Hountz D, Coddington J, Foli KJ and Thorlton J (2017) Increasing colorectal cancer screening using a quality improvement approach in a nurse-managed primary care clinic. Journal of Healthcare Quality 39, 379–390. [DOI] [PubMed] [Google Scholar]
  44. Hsiang EY, Mehta SJ, Small DS, Rareshide CAL, Snider CK, Day SC and Patel MS (2019) Association of an active choice intervention in the electronic health record directed to medical assistants with clinician ordering and patient completion of breast and colorectal cancer screening tests. JAMA Network Open 2, e1915619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Hussain WA, Aurand W, Onuorah N, Krstevski G, Markert R, Springer K and Agrawal S (2021) Improving fecal immunochemical testing rates for colon cancer screening in the outpatient setting. Southern Medical Journal 114, 77–80. [DOI] [PubMed] [Google Scholar]
  46. Hwang AS, Harding AS, Chang Y, O’Keefe SM, Horn DM and Clark AL (2019) An audit and feedback intervention to improve internal medicine residents’ performance on ambulatory quality measures: a randomized controlled trial. Population Health Management 22, 529–535. [DOI] [PubMed] [Google Scholar]
  47. Jonah L, Pefoyo AK, Lee A, Hader J, Strasberg S, Kupets R, Chiarelli AM and Tinmouth J (2017) Evaluation of the effect of an audit and feedback reporting tool on screening participation: the Primary Care Screening Activity Report (PCSAR). Preventive Medicine 96, 135–143. [DOI] [PubMed] [Google Scholar]
  48. Jones B, Vaux E and Olsson-Brown A (2019) How to get started in quality improvement. British Medical Journal 364, k5408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Jones RT, Schott M, Leverence R and Cancino RS (2022) Practice transformation to improve cancer screening outcomes at an academic medical center. American Journal of Medical Quality: The Official Journal of the American College of Medical Quality 37 , 361–368. [DOI] [PubMed] [Google Scholar]
  50. Jung HY, Unruh MA, Vest JR, Casalino LP, Kern LM, Grinspan ZM, Bao YH, Kaushal R and Investigators H (2017) Physician participation in meaningful use and quality of care for medicare fee-for-service enrollees. Journal of the American Geriatrics Society 65, 608–613. [DOI] [PubMed] [Google Scholar]
  51. Kaczorowski J, Hearps SJ, Lohfeld L, Goeree R, Donald F, Burgess K and Sebaldt RJ (2013) Effect of provider and patient reminders, deployment of nurse practitioners, and financial incentives on cervical and breast cancer screening rates. Canadian Family Physician 59, e282–e289. [PMC free article] [PubMed] [Google Scholar]
  52. Kiran T, Wilton AS, Moineddin R, Paszat L and Glazier RH (2014) Effect of payment incentives on cancer screening in Ontario primary care. Annals Family Medicine 12, 317–323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Kirschner K, Braspenning J, Akkermans RP, Jacobs JE and Grol R (2013) Assessment of a pay-for-performance program in primary care designed by target users. Family Practice 30, 161–171. [DOI] [PubMed] [Google Scholar]
  54. Klarenbach S, Sims-Jones N, Lewin G, Singh H, Theriault G, Tonelli M, Doull M, Courage S, Garcia AJ, Thombs BD and Canadian Task Force on Preventive Health, C. (2018) Recommendations on screening for breast cancer in women aged 40–74 years who are not at increased risk for breast cancer. Canadian Medical Association Journal 190, E1441–E1451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Mader EM, Fox CH, Epling JW, Noronha GJ, Swanger CM, Wisniewski AM, Vitale K, Norton AL and Morley CP (2016) A practice facilitation and academic detailing intervention can improve cancer screening rates in primary care safety net clinics. Journal of the American Board of Family Medicine 29, 533–542. [DOI] [PubMed] [Google Scholar]
  56. Marx R, Tse WM, Golden L and Johnson EC (2016) Increasing colorectal cancer screening at community-based primary care clinics in San Francisco. Journal of Public Health Management Practice 22, 466–471. [DOI] [PubMed] [Google Scholar]
  57. McCowan C, McSkimming P, Papworth R, Kotzur M, McConnachie A, MacDonald S, Wyke S, Crighton E, Campbell C, Weller D, Steele RJC and Robb KA (2019) Comparing uptake across breast, cervical and bowel screening at an individual level: a retrospective cohort study. British Journal Cancer 121, 710–714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Moen KA, Kumar B, Igland J and Diaz E (2020) Effect of an intervention in general practice to increase the participation of immigrants in cervical cancer screening: a cluster randomized clinical trial. JAMA Network Open 3, e201903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Moore GF, Audrey S, Barker M, Bond L, Bonell C, Hardeman W, Moore L, O’Cathain A, Tinati T, Wight D and Baird J (2015) Process evaluation of complex interventions: medical Research Council guidance. British Medical Journal 350, h1258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Muthukrishnan M, Arnold LD and James AS (2019) Patients’ self-reported barriers to colon cancer screening in federally qualified health center settings. Preventive Medical Reports 15, 100896. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. National Health Service (2021) Bowel cancer screening [Online]. Retrieved July 7 2021 from https://www.nhs.uk/conditions/bowel-cancer-screening/
  62. Nguyen KH, Chien AT, Meyers DJ, Li Z, Singer SJ and Rosenthal MB (2020) Team-based primary care practice transformation initiative and changes in patient experience and recommended cancer screening rates. Inquiry: A Journal of Medical Care Organization, Provision and Financing 57, 46958020952911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Ontario Health (2021) Ontario cancer screening performance report 2020. Toronto: Ontario Health. [Google Scholar]
  64. Ornstein S, Nemeth LS, Jenkins RG and Nietert PJ (2010) Colorectal cancer screening in primary care: translating research into practice. Medicine Care 48, 900–906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hrobjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P and Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. British Medical Journal 372, n71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Popay J, Roberts H, Sowden A, Petticrew M, Arai L, Rodgers M, Britten N, Roen K and Duffy S (2006) Guidance on the conduct of narrative synthesis in systematic reviews. A product from ESRC methods programme. Lancaster, UK: Institute of Health Research.
  67. Potter MB, Yu TM, Gildengorin G, Yu AY, Chan K, McPhee SJ, Green LW and Walsh JM (2011) Adaptation of the FLU-FOBT Program for a primary care clinic serving a low-income Chinese American community: new evidence of effectiveness. Journal of Health Care for the Poor and Underserved 22, 284–295. [DOI] [PubMed] [Google Scholar]
  68. Price-Haywood EG, Harden-Barrios J and Cooper LA (2014) Comparative effectiveness of audit-feedback versus additional physician communication training to improve cancer screening for patients with limited health literacy. Journal of General Internal Medicine 29, 1113–1121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Radde K, Gottschalk A, Bussas U, Schulein S, Schriefer D, Seifert U, Neumann A, Kaiser M, Blettner M and Klug SJ (2016) Invitation to cervical cancer screening does increase participation in Germany: results from the MARZY study. International Journal of Cancer 139, 1018–1030. [DOI] [PubMed] [Google Scholar]
  70. Rat C, Pogu C, Le Donne D, Latour C, Bianco G, Nanin F, Cowppli-Bony A, Gaultier A and Nguyen JM (2017) Effect of physician notification regarding nonadherence to colorectal cancer screening on patient participation in fecal immunochemical test cancer screening a randomized clinical trial. JAMA-Journal of the American Medical Association 318, 816–824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Ruggeri CE, Reed RE, Coyle B, Stoltzfus J, Fioravanti G and Tehrani R (2020) Closing the gap: a resident-led quality improvement project to improve colorectal cancer screening in primary care community clinics. Journal of Graduate Medical Education 12, 104–108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Schliemann D, Su TT, Paramasivam D, Treanor C, Dahlui M, Loh SY and Donnelly M (2019) Effectiveness of mass and small media campaigns to improve cancer awareness and screening rates in Asia: a systematic review. Journal of Global Oncology 5, 1–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Shaw EK, Ohman-Strickland PA, Piasecki A, Hudson SV, Ferrante JM, McDaniel RR Jr, Nutting PA and Crabtree BF (2013) Effects of facilitated team meetings and learning collaboratives on colorectal cancer screening rates in primary care practices: a cluster randomized trial. Annals Family Medicine 11, 220–228, S1–S8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Skivington K, Matthews L, Simpson SA, Craig P, Baird J, Blazeby JM, Boyd KA, Craig N, French DP, McIntosh E, Petticrew M, Rycroft-Malone J, White M and Moore L (2021) A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance. British Medicine Journal 374, n2061. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Sun A, Tsoh JY, Tong EK, Cheng J, Chow EA, Stewart SL and Nguyen TT (2018) A physician-initiated intervention to increase colorectal cancer screening in Chinese patients. Cancer 124 (Suppl 7), 1568–1575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Suwankhong D and Liamputtong P (2018) Early detection of breast cancer and barrier to screening programmes amongst Thai migrant women in Australia: a qualitative study. Asian Pacific Journal of Cancer Prevention 19, 1089–1097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. The Royal Australian College of General Practitioners (2018) Guidelines for preventive activities in general practice, 9th, updated ed.. East Melbourne, VIC: RACGP. [Google Scholar]
  78. The World Bank (2022) High income [Online]. Retrieved May 7 2022 from https://data.worldbank.org/country/XD
  79. Thomson O’Brien MA, Oxman AD, Davis DA, Haynes RB, Freemantle N and Harvey EL (2000) Audit and feedback versus alternative strategies: effects on professional practice and health care outcomes. Cochrane Database System Reviews 2, CD000260. [DOI] [PubMed] [Google Scholar]
  80. Vaisson G, Witteman HO, Chipenda-Dansokho S, Saragosa M, Bouck Z, Bravo CA, Desveaux L, Llovet D, Presseau J, Taljaard M, Umar S, Grimshaw JM, Tinmouth J and Ivers NM (2019) Testing e-mail content to encourage physicians to access an audit and feedback tool: a factorial randomized experiment. Current Oncology 26, 205–216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Verbunt E, Boyd L, Creagh N, Milley K, Emery J, Nightingale C and Kelaher M (2022) Health care system factors influencing primary healthcare workers’ engagement in national cancer screening programs: a qualitative study. Australian and New Zealand Journal of Public Health 46, 858–864. [DOI] [PubMed] [Google Scholar]
  82. Walker-Smith TL and Baldwin S (2020) A quality improvement initiative: improving mammogram screening rates among low-income Hispanic women in primary care. Journal of Doctoral Nursing Practice 13, 71–78. [DOI] [PubMed] [Google Scholar]
  83. Walsh J, Potter M, Salazar R, Ozer E, Gildengorin G, Dass N and Green L (2020) PreView: a randomized trial of a multi-site intervention in diverse primary care to increase rates of age-appropriate cancer screening. Journal of General Internal Medicine 35, 449–456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Walsh JM, Gildengorin G, Green LW, Jenkins J and Potter MB (2012) The FLU-FOBT Program in community clinics: durable benefits of a randomized controlled trial. Health Education Research 27, 886–894. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Wang JHY, Ma GX, Liang WC, Tan Y, Makambi KH, Dong RC, Vernon SW, Tu SP and Mandelblatt JS (2018) Physician intervention and Chinese Americans’ colorectal cancer screening. American Journal of Health Behavior 42, 13–26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Weiner BJ, Rohweder CL, Scott JE, Teal R, Slade A, Deal AM, Jihad N and Wolf M (2017) Using practice facilitation to increase rates of colorectal cancer screening in community health centers, North Carolina, 2012–2013: feasibility, facilitators, and barriers. Prevenying Chronic Disease 14, E66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Wender RC (1993) Cancer screening and prevention in primary care. Obstacles for physicians. Cancer 72, 1093–1099. [DOI] [PubMed] [Google Scholar]
  88. Willemse A, Jadalla A, Conahan L, Sarff L and Brady M (2022) GetFIT for CRC: nurse practitioner-led program to improve colorectal cancer screening. The Journal for Nurse Practitioners 18, 968–975. [Google Scholar]
  89. Wu CA, Mulder AL, Zai AH, Hu Y, Costa M, Tishler LW, Saltzman JR, Ellner AL and Bitton A (2016) A population management system for improving colorectal cancer screening in a primary care setting. Journal of Evaluation in Clinical Practice 22, 319–328. [DOI] [PubMed] [Google Scholar]
  90. Yarnall KS, Pollak KI, Ostbye T, Krause KM and Michener JL (2003) Primary care: is there enough time for prevention? American Journal of Public Health 93, 635–641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Yeh PT, Kennedy CE, De Vuyst H and Narasimhan M (2019) Self-sampling for human papillomavirus (HPV) testing: a systematic review and meta-analysis. BMJ Global Health 4, e001351. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Verbunt et al. supplementary material 1

Verbunt et al. supplementary material

Verbunt et al. supplementary material 2

Verbunt et al. supplementary material


Articles from Primary Health Care Research & Development are provided here courtesy of Cambridge University Press

RESOURCES